Lopid and Radiculopathy - a phase IV clinical study of FDA data

Summary:

Radiculopathy is reported as a side effect among people who take Lopid (gemfibrozil), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Vioxx, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Radiculopathy when taking Lopid. It is created by eHealthMe based on reports of 9,538 people who have side effects when taking Lopid from the FDA, and is updated regularly.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

What is Radiculopathy?

Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly) is found to be associated with 740 drugs and 608 conditions by eHealthMe. Check the latest studies of Radiculopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

9,538 people reported to have side effects when taking Lopid.
Among them, 31 people (0.33%) have Radiculopathy.

Could Lopid cause Radiculopathy?

Among these 31 people:

How long have people been on Lopid when they have Radiculopathy? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Radiculopathy when taking Lopid? *

  • female: 16.13 %
  • male: 83.87 %

What is the age of people who have Radiculopathy when taking Lopid? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 83.33 %
  • 60+: 16.67 %

What are other drugs people take besides Lopid? *

  1. Celebrex: 12 people, 38.71%
  2. Vioxx: 12 people, 38.71%
  3. Robaxin: 10 people, 32.26%
  4. Catapres: 10 people, 32.26%
  5. Prilosec: 10 people, 32.26%
  6. Flonase: 10 people, 32.26%
  7. Reglan: 10 people, 32.26%
  8. Glipizide: 9 people, 29.03%
  9. Atenolol: 8 people, 25.81%
  10. Simvastatin: 8 people, 25.81%

What are other side effects people have besides Radiculopathy? *

  1. Fall: 14 people, 45.16%
  2. Sleep Apnea Syndrome: 14 people, 45.16%
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 13 people, 41.94%
  4. High Blood Pressure: 12 people, 38.71%
  5. Deafness Neurosensory: 11 people, 35.48%
  6. Dizziness: 11 people, 35.48%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 11 people, 35.48%
  8. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 11 people, 35.48%
  9. Head Injury: 10 people, 32.26%
  10. Cerebellar Infarction (impaired blood circulation to cerebellum): 10 people, 32.26%

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 25.81%
  2. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 5 people, 16.13%
  3. Depression: 4 people, 12.90%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 12.90%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
  6. Pain: 2 people, 6.45%
  7. Ill-Defined Disorder: 2 people, 6.45%
  8. Diabetes: 2 people, 6.45%
  9. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.23%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Lopid and have Radiculopathy?

- Check whether Radiculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopid:

Radiculopathy treatments and more:

How severe was Radiculopathy and when was it recovered:

Expand to all the drugs that have ingredients of gemfibrozil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Radiculopathy:

Browse all the conditions that are associated with Radiculopathy:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Lopid) and Lopid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: